Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

Large-scale trials presented at the European Society of Cardiology Congress showed that vaccines against influenza and ...

Results of a new study support using semaglutide and tirzepatide to reduce risk in patients with cardiometabolic heart ...

HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for metabolic diseases, announced that ...

As Random Contrast Learning™ enters a new chapter of growth and adoption, Lumina AI announces the return of co-inventors, Ben ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from ACHIEVE-3, an open-label randomized Phase 3 clinical trial evaluating the safety and efficacy of orforglipron compared ...

Cybersecurity training programs as implemented today by most large companies do little to reduce the risk that employees will ...

Osteopathic Manipulative Treatment (OMT) enhances immune responses to COVID-19 vaccination, according to a recent study ...

A growing body of research underscores that Alzheimer’s and cognitive decline are not inevitable parts of aging.

Five trending topics of the week: omega-3s may protect against Alzheimer's, comparing whey and clear protein powders, and a case for drinking more matcha ...

Feeding infants blueberries as one of their first solid foods could help strengthen their immune systems and support long-term gut health, according to new research from the University of Colorado ...